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We performed a 15-month study using 11 clinical strains and 1 control strain (ATCC 27853) ofPseudomonas
aeruginosa to determine whether changes in the manufacturing process of Sensititre predried panels result in
a reliable test of susceptibility to imipenem. MIC and breakpoint susceptibility results remained stable during
the manufacturer's recommended shelf life of 18 months and compared well with standard agar disk diffusion
and broth macrodilution results. Imipenem concentrations measured by high-pressure liquid chromatography
were acceptable through 15 months but declined in the breakpoint panels by approximately 50%o at 18 months.
Between 9 months and panel expiration, 13 of 141 (9%Yo) of the MIC panel packages had moisture entry, as
indicated by pink desiccants, with a resultant loss of imipenem activity of 32 to 100%0. It appears that the new
manufacturing process produces MIC panels that are reliable for imipenem susceptibility testing until the
labeled expiration date, provided that packages containing pink desiccants are not used.
Reliable in vitro testing of the susceptibility of clinical
isolates of Pseudomonas aeruginosa to imipenem is of para-
mount importance to good patient care. Unfortunately, imi-
penem is labile in storage and during incubation at 35°C,
making in vitro testing problematic (1). Resistance among
clinical isolates of P. aeruginosa to imipenem appears to be
increasing (5, 7, 9) and must be differentiated from false
resistance due to degradation of the compound in commer-
cially prepared dry-format and frozen panels, in solutions
stored at room temperature, and as found in previous studies,
in commercially prepared predried broth microdilution panels
(Sensititre; Radiometer America Inc., Westlake, Ohio) (8, 11).
Concern over drug degradation prompted the vendor to
change the manufacturing process in an attempt to increase
the stability of imipenem in Sensititre panels and to modify the
expiration date to limit the shelf life of new panels from 24 to
18 months. In addition to a loss of potency over time, other
potential factors affecting a laboratory's ability to monitor the
reliability of testing of the susceptibility of organisms to
imipenem are variations in lots of Mueller-Hinton (MH)
broth, multiple passaging of the control strain of P. aeruginosa,
and moisture in stored dry-format panels (6, 8, 11). Moreover,
the zinc concentration in MH agar has been shown to affect the
MIC of imipenem for P. aeruginosa (2) and may affect suscep-
tibility testing by other methods. More difficulties have been
encountered when testing P. aeruginosa, since this organism
requires for inhibition higher concentrations of imipenem,
closer to the breakpoint (BP) values, than those required by
members of the family Enterobacteriaceae. Because of earlier
reports of the varying performance of Sensititre panels, our
objective was to conduct a rigorous study in which direct
measurement of imipenem concentrations in the test panels
and the effect of the age of the panels on susceptibility results
obtained in the microbiology laboratory were used to assess the
reliability of the currently available BP and MIC panels during
their entire shelf life.
(This work was presented in part at the 93rd General
* Corresponding author. Mailing address: Medical Center of Cen-
tral Massachusetts, 119 Belmont St. Worcester, MA 01605. Phone:
(508) 793-6172.
Meeting of the American Society for Microbiology, 1993,
Atlanta, Ga. [3].)
Sensititre system. Sensititre is a commercially packaged
system for quantitative and qualitative susceptibility testing.
Antimicrobial agents at appropriate concentrations are put
into wells of a microdilution panel, which is then dried and
packaged for storage at room temperature. Each package
contains a silica gel desiccant that changes color from blue to
pink when moisture is present. The system utilizes a nephe-
lometer for standardizing the inoculum. An autoinoculator
dispenses 50 RI of broth containing the inoculum into each
well. Following incubation, panels can be read manually or by
an autoreader, which measures growth by fluorescence. A
computer program converts this measurement to a BP result or
MIC (4, 10).
Organisms. Eleven unique clinical isolates of P. aeruginosa
collected at the Medical Center of Central Massachusetts and
one P. aeruginosa control strain (ATCC 27853) were stored in
multiple copies at -70°C in brain heart infusion semisolid agar
(Difco Laboratories, Detroit, Mich.) and subcultured on Tryp-
ticase soy agar with 5% sheep blood (BBL) before each testing
period. Organisms were selected to include those requiring a
range of imipenem MICs from '1.0 to 16 ,ug/ml as determined
by the Sensititre method at the time of purchase of the panels
and 2.0 to 32 ,ug/ml as determined by broth macrodilution
testing. These organisms (Table 1) were selected so that wells
in the MIC panel containing low and higher imipenem con-
centrations (1.0 to 64 ,ug/ml) would be biologically assayed and
that the performance of new and older panels could be
measured for accuracy in correctly detecting both susceptible
and resistant strains. Since the BP panels contain only two
wells with 4 and 8 jig of imipenem per ml, there are fewer
datum points within the range of these panels.
Inoculum preparation. Several colonies from overnight in-
cubation on Trypticase soy agar-5% sheep blood plates at 35°C
were suspended in demineralized water to match a 0.5 McFar-
land turbidity standard. Predried fluorogenic enzyme substrate
paper strips were added to cation-supplemented MH broth
with N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid
(TES) (Sensititre) and were incubated for 15 min at room
temperature. A calibrated pipette was used to transfer 10 RI of
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TABLE 1. Comparison of susceptibility test results for imipenem by using broth macrodilution and Sensititre panels to examine 12 strains of
P. aeruginosa
Results of Sensititre panels tested in duplicate
Strain Broth macrodilution Imipenem MIC (pg/ml) BPa BP rangeb
(Lg/ml) At time of At expiration Rangeb At time of At expiration Interpretation MIC (,g/ml)
purchase purchase
ATCC27853 4 1, s1 2, 2 1-4 S, S S, S .54
Psa27 2 s1, 1 1, s1 s1-2 S, S S, S S s4
Psa20 2 1, 1 s1, s1 <1 S, S S, S S s4
Psa4 2 1, 1 2, 2 s1-2 S, S S, S S s4
Psa 1 2 <1, 2 4, 2 1-4 S, S S, S S c4
Psa 14 4 1, s1 sl, 2 1-4 S, S S, MS S-MS 4-8
Psa 18 4 s, <1 2, 2 s1-2 S, S S, S S c4
Psa 16 4 <1, s 4,4 1-4 S, S S, S S s4
Psa 31 8 4, 4 4, 16 4-16 S, S MS, MS S-MS 4-8
Psa 9 16 8, 8 16, 16 8-16 MS, MS R, R MS-R 8->8
Psa 21 32 8, 8 4, 32 2-32 MS, MS R, R MS-R 8->8
Psa 25 32 16, 16 32, 32 16-32 R, R R, R R >8
a S, susceptible; MS, moderately susceptible; R, resistant.
b Includes all results obtained during the 15-month study period.
the inoculum into the MH broth, resulting in a bacterial
concentration of 105 CFU/ml.
Susceptibility testing procedure. Isolates were tested for
susceptibility to imipenem by a standard Bauer-Kirby agar disk
diffusion method according to accepted guidelines (6a). Stan-
dard broth macrodilution testing was performed using MH
broth and imipenem standard powder (946 ,ug/mg; lot 7372V;
expiration, December 1993; Merck Human Health Div., West
Point, Pa.). Broth microdilution testing using Sensititre MIC
and custom BP panels was performed according to the manu-
facturer's instructions using a single lot of each type of panel
stored at room temperature under usual laboratory conditions.
Panels were received 15 months prior to the stated expiration
date, 3 months after manufacture, so that testing was done 3,
4, 6, 9, 12, 15, and 18 months after the date of panel
manufacture. Panels with the desiccant of the desired blue
color were inoculated with the Sensititre autoinoculator and
were incubated at 35°C in room air for 18 to 24 h. The 12
isolates were run in duplicate by different technologists and
interpreted both by the Sensititre autoreader and visually with
a mirrored-light view box. A difference of 1 twofold MIC
dilution or one panel well was considered acceptable perfor-
mance in comparison of susceptibility results.
Assay of imipenem concentrations. At study time points
between 4 and 18 months, the concentration of imipenem at
each dilution in each type of panel was assayed by high-
pressure liquid chromatography (HPLC) (Merck Manufactur-
ing Div., Elkton, Va.). Imipenem was reconstituted with phos-
phate buffer, pH 6.8, and concentrations were determined
after incubation for 1 h at room temperature. Assay results
were determined with an imipenem reference standard in a pH
6.8 buffer matrix.
Results. Of the 12 isolates chosen, 9 were susceptible and 3
were resistant to imipenem by Bauer-Kirby testing, and these
results were in agreement with the results obtained by broth
macrodilution testing. With the Sensititre panels and the
autoreader, and comparing the time of panel receipt with the
panel expiration date, there was acceptable agreement in test
results throughout the time that the panels were stored (Table
1). We observed only one (strain Psa 16) notable (>1 twofold
dilution and sustained in duplicate testing) change (MIC rose
from z1 to 4 ,ug/ml) in the susceptibilities of the 12 P.
aeruginosa isolates to imipenem. Test-to-test variability (great-
er than 1-tube-dilution difference in MIC) was observed
among both the susceptible and resistant strains and occurred
as frequently between tests done at the same time point as
between those done at different time points. The control strain
tested within the desired range in both the MIC and BP panels
TABLE 2. Labeled versus measured (within 1 h of reconstitution) concentrations of imipenem in Sensititre panels tested by HPLC
Imipenem concn (,ug/ml)
Plate Measured at indicated time (mo) after plate manufacture:
Labeled
4 6 9 12 15 18a
MIC 64 71.0 66.4 66.4 59.3 88.2 61.2
32 39.0 36.4 36.0 33.3 34.3 27.4
16 16.7 16.8 16.4 13.7 15.4 10.8
8 8.0 8.3 8.1 6.4 7.8 5.3
4 3.9 4.2 3.9 3.2 4.5 3.5
2 1.8 1.8 1.8 1.7 2.2 2.2
1 1.1 1.2 1.2 1.0 1.3 1.5
BP 8 8.4 7.7 5.9 6.4 6.0 4.5
4 3.8 3.5 3.6 3.1 2.9 2.0
a Manufacturer's expiration date.
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FIG. 1. Comparison of labeled concentration of imipenem with concentration measured by HPLC in wells from panels contained in four
different packages with pink desiccants. Different symbols represent different panels. The dashed line represents the ideal in which measured
concentration would equal the target concentration. Percentages of ideal are for the 64-,ug/ml well.
during the entire panel shelf life, but the MIC increased from
.1.0 pLg/ml at the time of panel purchase to 4.0 jig/ml at 12 and
15 months but then fell to 2.0 ,ug/ml at panel expiration.
Results of duplicate testing at each time point were within 1
twofold dilution in 96.5% of the paired assays. Visually deter-
mined MICs agreed with automated readings in 98.6% of the
determinations. Very major errors (a resistant organism la-
beled as susceptible) occurred only when testing strain Psa 21.
The MIC for this strain, which was resistant by disk diffusion
and broth macrodilution testing, was in the susceptible range in
4 of 14 determinations by the Sensititre system. We cannot
explain the phenomenon, but it could be due to instrument
variability or a characteristic unique to this strain. Results bore
no relationship to the age of the panels.
Imipenem concentrations measured by HPLC correlated
with labeled values for MIC panels tested at 1 h after recon-
stitution (Table 2). HPLC measurements using the BP panels
revealed similar results, but at 18 months a 50% decline in
imipenem concentration occurred. After storage of the panels
for 6 months in our laboratory, pink silica gel desiccants,
indicating moisture, were found. Between 9 months and panel
expiration, 13 of 141 (9%) of the packaged panels showed pink
desiccants and would need to be discarded by a clinical
laboratory. HPLC showed a marked decline in imipenem
concentration in these panels, ranging from 68 to 5% of
labeled concentration in the 64-jig/ml well. A corresponding
decrease was seen in all the MIC panel wells, as illustrated in
Fig. 1.
Discussion. Since imipenem degrades more rapidly than
many other antimicrobial agents, susceptibility testing using
both frozen and dry-format broth microdilution panels has
been problematic (1, 6, 8, 11). On the basis of our longitudinal
testing results, we conclude that the revised Sensititre manu-
facturing process produces MIC and BP panels that are
adequate for testing imipenem susceptibility of P. aeruginosa
for up to the recommended panel expiration date. There are
individual strains in this study that produced variable test
results that cannot be explained, but a small number of minor
errors are typical when any microdilution susceptibility testing
product is evaluated. Despite the low imipenem concentrations
found in some wells by HPLC, susceptibility results using the
bacterial strains were stable throughout the 18-month period.
A 50% loss of activity in HPLC is theoretically equivalent to a
difference of 1 twofold dilution in determining an MIC result.
Thus, a 50% loss of imipenem activity would be difficult for a
clinical laboratory to detect. This loss would be more likely to
result in false detection of resistance when testing strains for
which MICs are close to the 4.0-,ug/ml susceptibility BP.
The number of unusable panels, as indicated by the presence
of pink desiccants in the packages, was high (9%) during the
last 9 months of the panels' shelf life, suggesting that a change
in manufacture or packaging may be necessary to decrease the
entry of moisture. Laboratory staff should carefully inspect the
desiccant package for a pink color, indicating contamination by
moisture, and should not use these panels because of marked
degradation of imipenem. In contrast to previous reports using
older panels, we found that the currently manufactured panels
provide reliable testing results with the control strain of P.
aeruginosa (ATCC 27853) when stored under usual laboratory
conditions for the manufacturer's recommended shelf life.
We thank Wesley T. Lee, lead lab supervisor, Quality Operations,
Merck Manufacturing Div., Elkton, Va., for the determination of
imipenem concentrations by HPLC. We thank Karen Amidon-Coelho
for secretarial support.
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